GO
Loading...

Dynavax Technologies Corp

More

  • Lightning Round: Coinstar, Lockheed Martin & More Wednesday, 6 Feb 2013 | 6:38 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Lightning Round: Ford, Sirius XM, Intel & More Tuesday, 16 Oct 2012 | 6:41 PM ET

    Cramer makes the call on viewer favorites.

  • 10 Stocks Boosting Little Funds to Big Returns Friday, 16 Mar 2012 | 12:38 PM ET

    There are a handful of small, actively managed mutual funds holding little more than a dozen or so stocks boasting returns above 22 percent this year. Their secret? Old-fashioned stock picking of lesser-known or undervalued companies.

  • Stocks Erase Gains as Bank Fears Rattle Market Tuesday, 26 Jan 2010 | 5:54 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks erased their gains just in time for the closing bell Tuesday as news that the Senate has scheduled a hearing on President Obama's bank proposal for next week rattled the market.

  • Confidence Lifts Stocks; Travelers Leads Dow Tuesday, 26 Jan 2010 | 3:07 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks bounced back Tuesday after a report showed consumer confidence rose for a third straight month.  Travelers led the Dow after beating earnings expectations.

  • Stocks Rebound After Confidence Boost Tuesday, 26 Jan 2010 | 11:56 AM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks bounced back Tuesday after a report showed consumer confidence rose for a third straight month.  Travelers led the Dow after beating earnings expectations.

  • Futures Off Lows on Earnings Strength Tuesday, 26 Jan 2010 | 7:21 AM ET
    Winterizing Your Portfolio - A CNBC Special Report

    U.S. stock index futures indicated a lower open for Wall Street Tuesday, with stock markets in Asia and Europe knocked down by news of monetary tightening in China.

  • Biotechnology company MedImmune said it expects to report first-quarter earnings nearly tripled from a year earlier, helped by higher sales of its respiratory drug Synagis.